Home » Topics » Regulatory

Regulatory
RSS

Roche seeks FDA approval for Xenical as adjunct in type 2 diabetes

March 23, 2001

Two new antiglaucoma drugs approved by FDA

March 19, 2001

Abbott and NaPro BioTherapeutics file ANDA for paclitaxel

March 19, 2001

New doses of Kadian approved in U.S.

March 15, 2001

Roche seeks FDA approval for Xeloda/Taxotere combination for the treatment of breast cancer

March 9, 2001

FDA approves multidose formulation of Serono's Gonal-F for ovarian stimulation

March 7, 2001

Faulding to market and sell NaPro's paclitaxel in Europe

March 5, 2001

CPMP issues positive opinion for new NeoRecormon indication

March 5, 2001

Early March launch for new antiallergic agent from Kyowa Hakko

Feb. 27, 2001

Iomed enrolls over 300 patients in phase III study for epicondylitis

Feb. 26, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.